Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01964898 · ClinicalTrials.gov registry record · NA
Post Acute Coronary Event Smoking Study
A NA study, sponsored by The Miriam Hospital.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT01964898: Completed NA study, sponsored by The Miriam Hospital.
NCT01964898 is a NA study that has completed, run by The Miriam Hospital. The registered enrollment target is 65 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01964898, a NA study, has completed, sponsored by The Miriam Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
Smoking and depressed mood are both predictive of mortality following Acute Coronary Syndrome. However, to date, no counseling treatment has been designed to target smoking cessation and manage mood in this population. This trial will test such a treatment based on Behavioral Activation, an approach that has shown promise as an integrated treatment for smoking and mood management in other populations.
Primary Outcome
No smoking, not even a puff, for 7 days; verified by carbon monoxide measurement. Results are adjusted for nicotine patch use and concurrent medication treatment targeting cessation.
Interventions
- DRUG Nicotine patch
- BEHAVIORAL Behavioral Activation (BA)
- BEHAVIORAL Standard Smoking Cessation Counseling
- OTHER Printed Self-help materials for Smoking Cessation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-04 |
| Phase | NA |
What the finished NCT01964898 record still lists
NCT01964898 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 4 interventions - of which Nicotine patch is the first listed.
NCT01964898 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01964898 about?
NCT01964898 is a clinical study titled "Post Acute Coronary Event Smoking Study". Smoking and depressed mood are both predictive of mortality following Acute Coronary Syndrome. However, to date, no counseling treatment has been designed to target smoking cessation and manage mood in this population. This trial will test such a treatment based on Behavioral Activation, an approach...
What is the current status of trial NCT01964898?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2013-10. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01964898?
The interventions under investigation include: Nicotine patch (DRUG), Behavioral Activation (BA) (BEHAVIORAL), Standard Smoking Cessation Counseling (BEHAVIORAL), Printed Self-help materials for Smoking Cessation (OTHER).
Who is sponsoring clinical trial NCT01964898?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01964898's enrollment target sits among peer trials
65 1144th of 2000 higher than 854 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia